seed
Stage
1
Investors
About
Surface Oncology is a clinical-stage biotechnology company developing therapies that target the immune-suppressive tumor microenvironment to treat cancer.
Explore Surface Oncology's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.